Fighting medication errors: Results of a study and reflections on causes and ways for prevention

International Journal of Risk and Safety in Medicine

Volumn 15, Issue 4/3, 2002, Pages 203-211

  Lepaux, D J ^a,e   Schmitt, E ^b,d   Dufay, E ^c,d  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Centre Hospitalier Montperrin   (France)

^c CENTRE HOSPITALIER   (France)

^d Assoc l'Assur Qualite T   (France)

^e Service Pharmacie   (France)

Author keywords

Drug utilization; Hospital; Medication error; Patient safety; Quality assurance

Indexed keywords

ARTICLE; DRUG UTILIZATION; ERROR; HOSPITAL; HUMAN; MORBIDITY; PRESCRIPTION; PREVENTION; QUALITY CONTROL; SAFETY;

EID: 0037657825     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. E.L. Allan, Calculating medication error rates, Am. J. Hosp. Pharm. 44 (1987), 1044-1045.
2. E.L. Allan and K.N. Barker, Fundamentals of medication error research, Am. J. Hosp. Pharm. 47 (1990), 555-571.
3. American Society of Hospital Pharmacists, ed., Guidelines on preventing medication errors in hospital, Am. J. Hosp. Pharm. 50 (1993), 305-314.
4. K.N. Barker and W.E. MacConnell, The problems of detecting medication errors in hospitals, Am. J. Hosp. Pharm. 19 (1962), 361-369.
5. K.N. Barker, R.L. Mikeal, R.E. Pearson, N.A. Illig and M.L. Morse, Medication errors in nursing homes and small hospitals, Am. J. Hosp. Pharm. 39 (1982), 987-991.
6. K.N. Barker, W.W. Kimbrough and W.M. Heller, The medication error problems in hospitals: I - The detection and the use of errors a measurement of medications systems, Hosp. Farmulary 1 (1966), 29-34.
7. D.W. Bates, D.L. Boyle, M.B. Van der Vliet, J. Schneider and L.L. Leape, Relationship between medication errors and adverse drug events, J. Gen. Intern. Med. 10 (1995), 199-205.
8. D.W. Bates, L.L. Leape and S. Petrycki, Incidence and preventability of adverse drug events in hospitalized adults, Gen. Intern. Med. 8 (1993), 289-294.
9. K. Belkacem, D.J. Lepaux and R. Oliger, Taux d'erreurs de médication en milieu hospitalier - Etude pilote du Centre Hospitalier de Jury-Lès- Metz, Presse Med. 30 (2001), 785-789.
10. K.V. Blum, S.R. Abel, C.J. Urbanski and J.M. Pierce, Medication error prevention by pharmacists, Am. J. Hosp. Pharm. 45 (1988), 1902-1903.
11. Canadian Society of Hospital Pharmacists, Guidelines for medication incident and medication discrepancy reporting in Canadian hospital, Can. J. Hosp. Pharm. 39 (1986), 67-69.
12. Chief Medical Officer, An organisation with a memory. A report of an expert group on learning from adverse events in the NHS - Figure 5.2: Some key steps in learning from adverse accidents. Stationnery office, ed., 2000.
13. G. Chu, R. Mantin, Y.M. Shen, G. Baskett and H. Sussmanm, Massive cisplatin overdose by accidental substitution for carboplatin, Cancer 73 (1993), 3707-3714.
14. M.R. Cohen, Safety alert - overdoses of Platinol® (cisplatin) and Paraplatin® (carboplatin), Hosp. Pharm. 27 (1992), 991-992.
15. M.R. Cohen and N.M. Davis, Developing safe and effective preprinted physician's order forms, Hosp. Pharm. 27 (1992), 508.
16. M.R. Cohen and J.L. Smetzer, Risk analysis and treatment, in: Medication Errors, M.R. Cohen, ed., American Pharmaceutical Association, 1999.
17. B.S. Dean and N.D. Barber, Validity and reliability of observational methods for studying medication administration errors, Am. J. Health Syst. Pharm. 58 (2001), 54-59.
18. C. Ducrot, D. Calavas, P. Sabatier and B. Faye, Qualitative interaction between the observer and the observed in veterinary epidemiology, Prev. Vet. Med. 34 (1998), 107-113.
19. E. Dufay, E. Schmitt, C. Kettani and J. Calop, Un réseau épidémiologique de l'erreur médicamenteuse, Pharm. Hosp. 33(135 Suppl.) (1998), 14-18.
20. T.A. Edgar, D.S. Lee and D.D. Cousins, Experience with a national medication error reporting program, Am. J. Hosp. Pharm. 51 (1994), 1335-1338.
21. J. Francoeur, Les accidents évitables dans la prestation des soins de santé - Effets indésirables et accidents évitables: Un cadre conceptuel, in: La gestion des risques, une priorité pour le réseau, Rapport du Comité ministériel du Ministère de la Santé et des Services Sociaux du Québec 2001 (web site: http://206.167.52.1/fr/document/ publication.nsf/961885cb24e4e9fd85256b1e00641a29/ 4a94b40fb9e9402885256a00007390f0?OpenDocument).
22. K. Hosotani, The QC Problem-Solving Approach: Solving Workplace Problems, the Japanese Way, 3A Corporation, 1989.
23. C. Jaubert de Beaujeu and J. Bureau, Comparaison de taux d'erreurs de dispensation des médicaments en fonction du mode de distribution, J. Pharm. Clin. (1988) (hors série II): 415-424.
24. A.-P.E. Joinville, E. Autret, F. Bavoux et al., Characteristics of medication errors in pediatrics, DICP Ann. Pharmacoth. 25 (1991), 113-118.
25. G. Langley, K. Nolan, T. Nolan, C. Norman and L. Provost, The Improvement Guide: A Practical Approach to Enhancing Organizational Performance, Jossey-Bass Publishers, 1996.
26. L.L. Leape, D.W. Bates, D.J. Cullen, J. Cooper, H.J. Demonaco, T. Gallivan, R. Hallisey, J. Ives, N. Laird and G. Laffel, Systems analysis of adverse drug events, J. Am. Med. Assoc. 1 (1995), 35-43.
27. L.L. Leape, A. Kabcenell, D.M. Berwick and J. Roessner, Reducing adverse drug events. Breakthrough series Guide, Institute for Healthcare Improvement, 1998.
28. D.J. Lepaux and K. Belkacem, Erreurs sur le remède et remèdes à l'erreur, Pharm. Hosp. 34 (1999), 9-16.
29. P. Lorino, Méthodes et pratiques de la performance - Le pilotage par les processus et les compétences, Editions d'organisation, 2001.
30. National Coordinating Council for Medication Errors Reporting and Prevention, NCC MERP Index for Categorizing Medication Errors Algorithm 2001 (web site: http://www.nccmerp.org).
31. No author listed, Cheers, ISMP Medication Safety Alert! 3 (1998).
32. No author listed, Décès par surdosage: une enquête est ouverte. Une infirmière et un interne du centre hospitalier Lyon Sud on été longuement interrogés, Le Progrès (8 février 2002).
33. No author listed, Design of preprinted cancer chemotherapy order forms is critical for patient safety, ISMP Medication Safety Alert! 1 (1996).
34. No author listed, Deux enquêtes pour "homicides involontaires" on été ouvertes après le décès de deux patients à la suite d'erreurs médicales, Le Monde (9 février 2002).
35. No author listed, Enquête à Lyon après un accident de surdosage, Le Quotidien du Médecin 7063 (2002).
36. No author listed, Erreur médicale: décès d'un patient, Lyon capitale 808 (2002).
37. No author listed, Error-prevention group issues prescription-writing recommendations, classification system, Am. J. Hosp. Pharm. 53 (1996), 2384.
38. No author listed, Medication error taxonomy available, Am. J. Health Syst. Pharm. 56 (1999), 314.
39. No author listed, Redesign of cisplatin packaging could signal new era of safer medication packaging, ISMP Medication Safety Alert! 1 (1996).
40. E. Pelus, M. Dellanegra, D. Charletty, N. Magnin, N. Petit and I. Meylan, Unité de préparation centralisée des cytotoxiques: de la mise en place à l'assurance-qualité J. Pharm. Clin. 17 (1998), 97-102.
41. G.A. Pepper, Errors in drug administration by nurses, Am. J. Health Sys. Pharm. 52 (1995), 390-395.
42. President and fellows of Harvard College, Harvard Business Review on Leadership, Harvard Business School Press, 1990, 1992, 1993, 1996, 1998.
43. Quality Interagency Coordination Task Force, ed., Doing What Counts for Patient Safety: Federal Actions to Reduce Medical Errors and Their Impact - Figure 1: Framework for identifying errors, in: Report of the Quality Interagency Coordination Task Force (QuIC) to the President 2000.
44. P. Queneau, J.M. Chabot, M. Rajaona, C. Boissier and P. Grandmottet, Iatrogénie observée en milieu hospitalier. I - Apropos de 109 cas colligés à partir d'une enquête transversale APNET, Bull. Adac. Natle Med. 176 (1992), 511-529.
45. J.T. Reason, Human Error, Cambridge University Press, 1990.
46. J.T. Reason, Human error: models and management, Brit. J. Med. 320 (2000), 768-770.
47. J.T. Reason, Managing the Risks of Organizational Accidents, Ashgate, 1997.
48. Résolution ResAP(2001)2 du Conseil de l'Europe sur le rôle du pharmacien dans le cadre de la sécurité sanitaire (adoptée par le Comité des Ministres, le 21 mars lors de la 746e réunion des Délégués des Ministres) 2001.
49. W.G. Sarrat, Conducting a security audit, J. Healthc. Prot. Manage. 16 (1999), 39-61.
50. E. Schmitt, Iatrogenèse médicamenteuse nosocomiale: Où est le risque?, Presse Med. 28 (1999), 970-972.
51. E. Schmitt, Le risque médicamenteux nosocomial. Circuit hospitalier du médicament et qualités des soins, Masson, Paris (Collection Evaluation et Statistique), 1999.
52. S. Shiba, A. Graham and D. Walden, A New American TQM. Four Practical Revolutions in Management, The Centre for Quality Management, 1993.
53. B. Zernikov, Accidental iatrogenic intoxications by cytotoxic drugs: Error analysis and practical preventive strategies, Drug Safety 21 (1999), 57-74.